Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
News-Medical.Net on MSN11d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
MolecuLern identified BLX-7006 as a novel small molecule capable of allosterically modulating GLP-1 receptor activity. Unlike many oral small-molecule GLP-1 therapies being developed—whose ...
Interesting Engineering on MSN13d
AI finds natural peptide that matches Ozempic’s weight loss power without side effectsStanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...
Once-a-weekly, prescription-based medicine, Mounjaro is a single molecule that selectively binds to and activates both GIP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback